US Bancorp’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54K | Sell |
306
-1,231
| -80% | -$6.2K | ﹤0.01% | 3897 |
|
|
2025
Q1 | $9.96K | Buy |
1,537
+996
| +184% | +$6.45K | ﹤0.01% | 3423 |
|
|
2024
Q4 | $3.97K | Sell |
541
-5,919
| -92% | -$43.4K | ﹤0.01% | 3701 |
|
|
2024
Q3 | $48.4K | Sell |
6,460
-1,276
| -16% | -$9.56K | ﹤0.01% | 2754 |
|
|
2024
Q2 | $68.9K | Sell |
7,736
-2,604
| -25% | -$23.2K | ﹤0.01% | 2509 |
|
|
2024
Q1 | $105K | Sell |
10,340
-1,069
| -9% | -$10.8K | ﹤0.01% | 2338 |
|
|
2023
Q4 | $115K | Buy |
11,409
+9,469
| +488% | +$95.3K | ﹤0.01% | 2287 |
|
|
2023
Q3 | $18.2K | Buy |
1,940
+1,170
| +152% | +$11K | ﹤0.01% | 2925 |
|
|
2023
Q2 | $18.9K | Buy |
770
+25
| +3% | +$613 | ﹤0.01% | 2978 |
|
|
2023
Q1 | $17.3K | Buy |
745
+11
| +1% | +$256 | ﹤0.01% | 3051 |
|
|
2022
Q4 | $18.6K | Buy |
734
+184
| +33% | +$4.66K | ﹤0.01% | 3019 |
|
|
2022
Q3 | $10K | Sell |
550
-432
| -44% | -$7.86K | ﹤0.01% | 3364 |
|
|
2022
Q2 | $25K | Buy |
982
+625
| +175% | +$15.9K | ﹤0.01% | 2927 |
|
|
2022
Q1 | $9K | Buy |
357
+66
| +23% | +$1.66K | ﹤0.01% | 3408 |
|
|
2021
Q4 | $12K | Sell |
291
-124
| -30% | -$5.11K | ﹤0.01% | 3343 |
|
|
2021
Q3 | $18K | Buy |
+415
| New | +$18K | ﹤0.01% | 3178 |
|
|
2021
Q1 | – | Sell |
-1,500
| Closed | -$40K | – | 3922 |
|
|
2020
Q4 | $40K | Hold |
1,500
| – | – | ﹤0.01% | 2608 |
|
|
2020
Q3 | $51K | Hold |
1,500
| – | – | ﹤0.01% | 2370 |
|
|
2020
Q2 | $61K | Buy |
+1,500
| New | +$61K | ﹤0.01% | 2307 |
|